Your browser doesn't support javascript.
loading
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
Van Praet, Charles; Rottey, Sylvie; Van Hende, Fransien; Pelgrims, Gino; Demey, Wim; Van Aelst, Filip; Wynendaele, Wim; Gil, Thierry; Schatteman, Peter; Filleul, Bertrand; Schallier, Denis; Machiels, Jean-Pascal; Schrijvers, Dirk; Everaert, Els; D'Hondt, Lionel; Werbrouck, Patrick; Vermeij, Joanna; Mebis, Jeroen; Clausse, Marylene; Rasschaert, Marika; Van Erps, Joanna; Verheezen, Jolanda; Van Haverbeke, Jan; Goeminne, Jean-Charles; Lumen, Nicolaas.
Afiliação
  • Van Praet C; Department of Urology, Ghent University Hospital, Ghent, Belgium. Electronic address: charles.vanpraet@uzgent.be.
  • Rottey S; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Van Hende F; Department of Medical Oncology, University Hospital Leuven, Leuven, Belgium.
  • Pelgrims G; Department of Medical Oncology, AZ Turnhout, Turnhout, Belgium.
  • Demey W; Department of Medical Oncology, AZ Klina, Kalmthout, Belgium.
  • Van Aelst F; Department of Medical Oncology, AZ Delta, Roeselare, Belgium.
  • Wynendaele W; Department of Medical Oncology, Imelda Hospital, Bonheiden, Belgium.
  • Gil T; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Schatteman P; Department of Urology, Onze-Lieve-Vrouw Hospital, Aalst, Belgium.
  • Filleul B; Department of Medical Oncology, Hopital De Jolimont, Haine Saint Paul, Belgium.
  • Schallier D; Department of Medical Oncology, University Hospital Brussels, Jette, Belgium.
  • Machiels JP; Department of Medical Oncology, Institut Roi Albert II, Cliniques universitaires Saint Luc, Brussels, Belgium.
  • Schrijvers D; Department of Medical Oncology, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium.
  • Everaert E; Department of Medical Oncology, AZ Nikolaas, Sint-Niklaas, Belgium.
  • D'Hondt L; Department of Medical Oncology, CHU Dinant-Godinne, Yvoir, Belgium.
  • Werbrouck P; Department of Urology, AZ Groeninge, Kortrijk, Belgium.
  • Vermeij J; Department of Medical Oncology, ZNA Jan Palfijn, Merksem, Belgium.
  • Mebis J; Department of Medical Oncology, AZ Jessa, Hasselt, Belgium.
  • Clausse M; Department of Medical Oncology, St Luc Bouge, Namur, Belgium.
  • Rasschaert M; Department of Medical Oncology, UZA/AZ Monica, Antwerp, Belgium.
  • Van Erps J; Department of Medical Oncology, Algemeen Stedelijk Ziekenhuis, Aalst, Belgium.
  • Verheezen J; Department of Medical Oncology, AZ Sint-Trudo, Sint-Truiden, Belgium.
  • Van Haverbeke J; Department of Urology, AZ Sint-Andries, Tielt, Belgium.
  • Goeminne JC; Department of Medical Oncology, Sainte-Elisabeth, Namur, Belgium.
  • Lumen N; Department of Urology, Ghent University Hospital, Ghent, Belgium.
Clin Genitourin Cancer ; 15(4): 502-508, 2017 08.
Article em En | MEDLINE | ID: mdl-28258960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prednisona / Taxoides / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prednisona / Taxoides / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article